U.S. flag

An official website of the United States government

NM_018129.4(PNPO):c.89C>T (p.Ala30Val) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 20, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000188505.1

Allele description [Variation Report for NM_018129.4(PNPO):c.89C>T (p.Ala30Val)]

NM_018129.4(PNPO):c.89C>T (p.Ala30Val)

Gene:
PNPO:pyridoxamine 5'-phosphate oxidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.32
Genomic location:
Preferred name:
NM_018129.4(PNPO):c.89C>T (p.Ala30Val)
Other names:
p.A30V:GCT>GTT
HGVS:
  • NC_000017.11:g.47941764C>T
  • NG_008744.1:g.5242C>T
  • NM_018129.4:c.89C>TMANE SELECT
  • NP_060599.1:p.Ala30Val
  • NC_000017.10:g.46019130C>T
  • NM_018129.3:c.89C>T
Protein change:
A30V
Links:
dbSNP: rs796052871
NCBI 1000 Genomes Browser:
rs796052871
Molecular consequence:
  • NM_018129.4:c.89C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000242119GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Dec 20, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000242119.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.Ala30Val (GCT>GTT): c.89 C>T in exon 1 of the PNPO gene (NM_018129.3). The Ala30Val missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Ala30Val alters a position that is well conserved through mammals in the PNPO protein and another missense mutation at a nearby codon (Asp33Val) has been reported in association with PNPO deficiency (Schmitt et al., 2010; Goyal et al., 2013). However, the Ala30Val amino substitution is conservative as both Alanine and Valine are uncharged, non-polar amino acid residues. In addition, in silico analysis predicts this variant likely has a benign effect on the protein structure/function. Therefore, based on the currently available information, it is unclear whether Ala30Val is a disease-causing mutation or a rare benign variant. The variant is found in INFANT-EPI panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 7, 2023